DK1264821T3 - Ny stilben-derivatkrystal samt fremgangsmåde til dens fremstilling - Google Patents
Ny stilben-derivatkrystal samt fremgangsmåde til dens fremstillingInfo
- Publication number
- DK1264821T3 DK1264821T3 DK01912367T DK01912367T DK1264821T3 DK 1264821 T3 DK1264821 T3 DK 1264821T3 DK 01912367 T DK01912367 T DK 01912367T DK 01912367 T DK01912367 T DK 01912367T DK 1264821 T3 DK1264821 T3 DK 1264821T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystal
- preparation
- well
- stilbene derivative
- type
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000076887 | 2000-03-17 | ||
| PCT/JP2001/002028 WO2001068587A1 (fr) | 2000-03-17 | 2001-03-14 | Nouveau derive de cristal de stilbene et son procede d'obtention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1264821T3 true DK1264821T3 (da) | 2008-09-08 |
Family
ID=18594552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01912367T DK1264821T3 (da) | 2000-03-17 | 2001-03-14 | Ny stilben-derivatkrystal samt fremgangsmåde til dens fremstilling |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6784315B2 (de) |
| EP (1) | EP1264821B1 (de) |
| JP (1) | JP4826051B2 (de) |
| CN (1) | CN1221527C (de) |
| AT (1) | ATE395325T1 (de) |
| AU (1) | AU2001241140A1 (de) |
| DE (1) | DE60133995D1 (de) |
| DK (1) | DK1264821T3 (de) |
| ES (1) | ES2306705T3 (de) |
| PT (1) | PT1264821E (de) |
| SI (1) | SI1264821T1 (de) |
| TW (1) | TWI291459B (de) |
| WO (1) | WO2001068587A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007254292A (ja) * | 2006-03-20 | 2007-10-04 | Nippon Polyurethane Ind Co Ltd | ジフェニルスルホンジイソシアネートの製造方法 |
| FR2953518B1 (fr) | 2009-12-03 | 2012-01-20 | Sanofi Aventis | Procede de preparation d'un derive de combretastatine |
| WO2013084150A1 (en) * | 2011-12-06 | 2013-06-13 | Sanofi | Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof |
| EP3184095A1 (de) | 2013-05-23 | 2017-06-28 | IP Gesellschaft für Management mbH | Verabreichungseinheiten die ein polymorph 1 von 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide beinhalten |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
-
2001
- 2001-03-14 AT AT01912367T patent/ATE395325T1/de active
- 2001-03-14 EP EP01912367A patent/EP1264821B1/de not_active Expired - Lifetime
- 2001-03-14 WO PCT/JP2001/002028 patent/WO2001068587A1/ja active IP Right Grant
- 2001-03-14 SI SI200130846T patent/SI1264821T1/sl unknown
- 2001-03-14 DE DE60133995T patent/DE60133995D1/de not_active Expired - Lifetime
- 2001-03-14 PT PT01912367T patent/PT1264821E/pt unknown
- 2001-03-14 CN CNB018067336A patent/CN1221527C/zh not_active Expired - Fee Related
- 2001-03-14 DK DK01912367T patent/DK1264821T3/da active
- 2001-03-14 AU AU2001241140A patent/AU2001241140A1/en not_active Abandoned
- 2001-03-14 JP JP2001567685A patent/JP4826051B2/ja not_active Expired - Fee Related
- 2001-03-14 ES ES01912367T patent/ES2306705T3/es not_active Expired - Lifetime
- 2001-03-16 TW TW090106261A patent/TWI291459B/zh not_active IP Right Cessation
-
2002
- 2002-09-16 US US10/243,649 patent/US6784315B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60133995D1 (de) | 2008-06-26 |
| TWI291459B (en) | 2007-12-21 |
| SI1264821T1 (sl) | 2008-10-31 |
| US20030065035A1 (en) | 2003-04-03 |
| EP1264821B1 (de) | 2008-05-14 |
| CN1418186A (zh) | 2003-05-14 |
| EP1264821A1 (de) | 2002-12-11 |
| PT1264821E (pt) | 2008-08-12 |
| ES2306705T3 (es) | 2008-11-16 |
| CN1221527C (zh) | 2005-10-05 |
| AU2001241140A1 (en) | 2001-09-24 |
| US6784315B2 (en) | 2004-08-31 |
| EP1264821A4 (de) | 2005-06-08 |
| WO2001068587A1 (fr) | 2001-09-20 |
| JP4826051B2 (ja) | 2011-11-30 |
| ATE395325T1 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU70901A (sh) | Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena | |
| HUT59400A (en) | Process for producing thiazole acylamino derivatives substituted with heterocyclic group, as well as pharmaceutical compositions comprising such compounds as active ingredient | |
| YU100302A (sh) | Novi $g (y) kristalni oblik tercijalne butilaminske soli perindoprila, postupak dobijanja i farmaceutske kompozicije koje sadrže isto | |
| WO2007018738A8 (en) | Fused bicycloheterocycle substituted quinuclidine derivatives | |
| NO20071547L (no) | Nye krystallinske og amorfe former av en triazolo(4,5-D)pyrimidinforbindelse | |
| HUP0401982A2 (hu) | Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| CA2331873A1 (en) | Fumagillol derivatives and processes for preparing the same | |
| WO2005113536A3 (en) | Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands | |
| HUT58036A (en) | Process for producing new substituted aminomethyl tetraline derivatives and their heterocyclic analogs, as well as pharmaceutical compositions comprising such compounds | |
| HUP0300370A2 (hu) | Antimikrobiális hatású 2-hidroxi-mutilin-karbamát-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20016389L (no) | Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav | |
| HU9400132D0 (en) | Tricyclic condensed heterocyclic compounds, process for producing them and pharmaceutical compositions contaning them as active component | |
| CA2135783A1 (en) | Substituted (arylalkoxybenzyl) amino-propanamide derivatives and process for their preparation | |
| DK1264821T3 (da) | Ny stilben-derivatkrystal samt fremgangsmåde til dens fremstilling | |
| AU2606592A (en) | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments | |
| BR0205683A (pt) | Processo para a preparação de derivados de piperazina, e, mesilato de um composto | |
| CA2060616A1 (en) | Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers | |
| BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
| WO2002059089A3 (en) | Process for the preparation of heterocyclic indene analogs | |
| TW200510357A (en) | Continuous process for the preparation of pesticides | |
| WO2002049992A3 (en) | Process for preparing fluorinated organic compounds | |
| NO20001541L (no) | Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem | |
| BR0112876A (pt) | Processo para preparação de discodermolida e seus análogos | |
| HU9202660D0 (en) | Method for producing a physical modification of a carbamoyl compound | |
| MXPA05013732A (es) | Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo. |